Muscle Weakness and Speech in Oculopharyngeal Muscular Dystrophy

被引:22
作者
Neel, Amy T. [1 ]
Palmer, Phyllis M. [1 ]
Sprouls, Gwyneth [1 ]
Morrison, Leslie [1 ]
机构
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源
JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH | 2015年 / 58卷 / 01期
关键词
OROPHARYNGEAL DYSPHAGIA; TONGUE STRENGTH; INTELLIGIBILITY; DYSARTHRIA; AGE; DYSFUNCTION; DYSPHONIA; STABILITY; GENDER; ADULTS;
D O I
10.1044/2014_JSLHR-S-13-0172
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Purpose: We documented speech and voice characteristics associated with oculopharyngeal muscular dystrophy (OPMD). Although it is a rare disease, OPMD offers the opportunity to study the impact of myopathic weakness on speech production in the absence of neurologic deficits in a relatively homogeneous group of speakers. Methods: Twelve individuals with OPMD and 12 healthy age-matched controls underwent comprehensive assessment of the speech mechanism including spirometry (respiratory support), nasometry (resonance balance), phonatory measures (pitch, loudness, and quality), articulatory measures (diadochokinetic rates, segment duration measures, spectral moments, and vowel space), tongue-to-palate strength measures during maximal isometric and speechlike tasks, quality-of-life questionnaire, and perceptual speech ratings by listeners. Results: Individuals with OPMD had substantially reduced tongue strength compared to the controls. However, little impact on speech and voice measures or on speech intelligibility was observed except for slower diadochokinetic rates. Conclusions: Despite having less than half the maximal tongue strength of healthy controls, the individuals with OPMD exhibited minimal speech deficits. The threshold of weakness required for noticeable speech impairment may not have been reached by this group of adults with OPMD.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 60 条
  • [1] Adamczyk D T, 1987, J Am Optom Assoc, V58, P408
  • [2] Awan SN, 2001, CLIN LINGUIST PHONET, V15, P117, DOI 10.3109/02699200109167642
  • [3] Oculopharyngeal muscular dystrophy in Hispanic new Mexicans
    Becher, MW
    Morrison, L
    Davis, LE
    Maki, WC
    King, MK
    Bicknell, JM
    Reinert, BL
    Bartolo, C
    Bear, DG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19): : 2437 - 2440
  • [4] Oculopharyngeal muscular dystrophy: clinical and CT findings
    Bilgen, C
    Bilgen, IG
    Sener, RN
    [J]. COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2001, 25 (06) : 527 - 529
  • [5] Boersma P., 2001, Glot International, V5, P341
  • [6] Recent studies on oculopharyngeal muscular dystrophy in Quebec
    Bouchard, JP
    Brais, B
    Brunet, D
    Gould, PV
    Rouleau, GA
    [J]. NEUROMUSCULAR DISORDERS, 1997, 7 : S22 - S29
  • [7] Neurogenic involvement in a case of oculopharyngeal muscular dystrophy
    Boukriche, Y
    Maisonobe, T
    Masson, C
    [J]. MUSCLE & NERVE, 2002, 25 (01) : 98 - 101
  • [8] Oculopharyngeal muscular dystrophy
    Brais, B
    Rouleau, GA
    Bouchard, JP
    Fardeau, M
    Tomé, FMS
    [J]. SEMINARS IN NEUROLOGY, 1999, 19 (01) : 59 - 66
  • [9] Comparison of nasalance scores obtained with the nasometer, the NasalView, and the OroNasal System
    Bressmann, T
    [J]. CLEFT PALATE-CRANIOFACIAL JOURNAL, 2005, 42 (04) : 423 - 433
  • [10] CHANG MH, 1993, MUSCLE NERVE, V16, P325